Does TauRx Drug Work by Oxidizing Tau?
In 2008, methylene blue created a stir when the drug’s sponsors reported that it slowed cognitive decline, while other scientists questioned that interpretation...
323 RESULTS
Sort By:
In 2008, methylene blue created a stir when the drug’s sponsors reported that it slowed cognitive decline, while other scientists questioned that interpretation...
In the AD field, most readers can count on one hand the companies that are widely known to have at least two drugs in sufficiently advanced stages to test combinations...
Just days after the first report of a highly eccentric translation mechanism in the major genetic forms of ALS and FTLD comes a second paper showing the same phenomenon...
White blood cells age quickly in post-menopausal women who carry the ApoE4 gene, but estrogen slows that decline...
Alzheimer's disease clinicians who have read the FDA's draft guidance on developing drug combinations consider it too vague to design trials with it...
Research suggests that deep-brain stimulation (DBS) can help at earlier stages—before motor complications get out of control...
Over the past year, chatter has been building about combination drug therapy as the "New New Thing" in Alzheimer’s disease research...
Keystone Symposia Meeting, Part 1—Alzheimer’s Disease: Genes, Cellular Pathways and Therapies Keystone Symposia Meeting, Part 2—Genetics and Epidemiology of AD Keystone Symposia Meeting, Part 3—Amyloid Precursor Protein Function Keystone Symposia Meeting,
Since the identification of the major ALS and FTLD gene C9ORF72 more than a year ago, scientists have been hunting for clues as to how it promotes disease...
Aside from a reasonable safety profile, the first published Phase 2 study of a blood-derived antibody preparation to treat Alzheimer’s disease looks inconclusive at best...
Harvard University will lead a $100 million research effort to study chronic traumatic encephalopathy and a host of other devastating health problems in professional footballers...
Though considered a strange beast in the grand scheme of brain disorders, could rapidly progressing dementia be more common than scientists think?...
Subtle alterations in the brain may help predict if people with mild cognitive impairment (MCI) will progress to Alzheimer’s disease...
Mounting evidence suggests that toxic proteins that cause Alzheimer's, Parkinson's, and other neurodegenerative diseases spread from neuron to neuron through the brain...
Scientists worldwide now perform amyloid imaging on scores of research participants to figure out how Aβ buildup relates to other markers of neurodegeneration...